As the nascent market for artificial intelligence (AI) in medical imaging develops, healthcare providers are faced with the question of how best to select, purchase and implement the rapidly expanding range of regulatory approved AI-enabled imaging applications and AI algorithms. 
Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater access to training, the appeal of ultrasound continues to expand in point-of-care (POC) markets. Estimated growth in the POC ultrasound (POCUS) market is expected to exceed $3 billion globally by 2025,1,2 up from $1.3 billion in 2018.

Every day, radiology practices are challenged to do more and perform better to improve patient care. An AI-driven workflow — powered by machine learning and advanced modeling — supports radiologists in this effort, helping to reduce turnaround times, improve clinical quality, and focus on patient treatment and outcomes.

Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.

Everything has room for improvement, right? Right. When it comes to cancer care, it is no different. Researchers, drug companies and technology innovators are constantly working to improve efficiency and efficacy, racing to create the best and most far-reaching cancer treatments. Significant resources are being dedicated to a rapidly evolving form of cancer therapy that is designed to be more effective than other existing options. However, new innovations have introduced new challenges, and emerging treatments must adapt to overcome these barriers. 
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam

The field of proton therapy is continuing to see explosive growth. In the past decade alone, technological advances have made proton therapy a more accessible, viable option for hospitals and radiotherapy centers. Moreover, clinical applications for proton therapy have evolved, enabling the treatment of a broad range of diseases. 

July 6, 2020 — Hoya Corp. and Hitachi, Ltd. announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which the parties will strengthen technical collaboration, and Hitachi will continue supplying diagnostic ultrasound systems and ultrasound sensor related parts used in EUS.

July 6, 2020 — Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island Hospital (RIH). This state-of-the-art platform leverages the superior resolution of digital mammography in the delivery of breast radiation therapy.

July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced that it has received U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now